Literature DB >> 21195488

Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Bryan A Bassig1, Peter D Inskip, Laurie Burdette, William R Shapiro, Robert G Selker, Howard A Fine, Jay S Loeffler, Peter M Black, Robert Dubrow, Alina V Brenner.   

Abstract

Few studies have examined the relationship between human leukocyte antigen (HLA) polymorphisms and adult glioma, particularly at class II loci. We evaluated the association between selected HLA class II polymorphisms and adult glioma in a large, hospital-based case-control study, using unconditional logistic regression. DQB1 06 (OR=1.67, 95% CI=1.17-2.39) and DRB1 13 (OR=1.69, 95% CI=1.08-2.64) alleles were associated with an increased risk of glioma, while the DQB1 05 allele showed an inverse association (OR=0.63, 95% CI=0.43-0.93). These results, which were of borderline significance once controlled for the false discovery rate, suggest a potential role for the DQB1 06, DQB1 05, and DRB1 13 alleles in glioma susceptibility.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195488      PMCID: PMC3074044          DOI: 10.1016/j.jneuroim.2010.11.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  52 in total

Review 1.  HLA-DQ6-mediated protection in IDDM.

Authors:  C B Sanjeevi
Journal:  Hum Immunol       Date:  2000-02       Impact factor: 2.850

2.  Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.

Authors:  Hyun Hor; Zoltán Kutalik; Yves Dauvilliers; Armand Valsesia; Gert J Lammers; Claire E H M Donjacour; Alex Iranzo; Joan Santamaria; Rosa Peraita Adrados; José L Vicario; Sebastiaan Overeem; Isabelle Arnulf; Ioannis Theodorou; Poul Jennum; Stine Knudsen; Claudio Bassetti; Johannes Mathis; Michel Lecendreux; Geert Mayer; Peter Geisler; Antonio Benetó; Brice Petit; Corinne Pfister; Julie Vienne Bürki; Gérard Didelot; Michel Billiard; Guadalupe Ercilla; Willem Verduijn; Frans H J Claas; Peter Vollenweider; Peter Vollenwider; Gerard Waeber; Dawn M Waterworth; Vincent Mooser; Raphaël Heinzer; Jacques S Beckmann; Sven Bergmann; Mehdi Tafti
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

3.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

4.  IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.

Authors:  Joseph L Wiemels; David Wilson; Chirag Patil; Joseph Patoka; Lucie McCoy; Terri Rice; Judith Schwartzbaum; Amy Heimberger; John H Sampson; Susan Chang; Michael Prados; John K Wiencke; Margaret Wrensch
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

5.  Common variation in genes related to innate immunity and risk of adult glioma.

Authors:  Preetha Rajaraman; Alina V Brenner; Mary Ann Butler; Sophia S Wang; Ruth M Pfeiffer; Avima M Ruder; Martha S Linet; Meredith Yeager; Zhaoming Wang; Nick Orr; Howard A Fine; Deukwoo Kwon; Gilles Thomas; Nathaniel Rothman; Peter D Inskip; Stephen J Chanock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

6.  The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease.

Authors:  Miryam Martinetti; Federico Biagi; Carla Badulli; Gerhard E Feurle; Christian Müller; Verena Moos; Thomas Schneider; Thomas Marth; Alessandra Marchese; Lucia Trotta; Sara Sachetto; Annamaria Pasi; Annalisa De Silvestri; Laura Salvaneschi; Gino R Corazza
Journal:  Gastroenterology       Date:  2009-01-27       Impact factor: 22.682

7.  HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation?

Authors:  Lilia Laadhar; Amina Toumi; Maryam Kallel-Sellami; Mondher Zitouni; Saadia Bouraoui; Ahmed Maherzi; Sondès Makni; Mongi Ben Hariz
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-11       Impact factor: 2.566

8.  Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.

Authors:  Felipe A Castro; Katri Haimila; Inna Sareneva; Markus Schmitt; Justo Lorenzo; Nelli Kunkel; Rajiv Kumar; Asta Försti; Lennart Kjellberg; Göran Hallmans; Matti Lehtinen; Kari Hemminki; Michael Pawlita
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

9.  Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.

Authors:  Dora Il'yasova; Bridget McCarthy; Jennifer Marcello; Joellen M Schildkraut; Patricia G Moorman; Bhuma Krishnamachari; Francis Ali-Osman; Darell D Bigner; Faith Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

10.  Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Authors:  Wei Song; Avima M Ruder; Liangyuan Hu; Yufeng Li; Rong Ni; Wenshuo Shao; Richard A Kaslow; MaryAnn Butler; Jianming Tang
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more
  3 in total

1.  Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL).

Authors:  Elias Orouji; Jalil Tavakkol Afshari; Zahra Badiee; Abbas Shirdel; Afrouz Alipour
Journal:  Int J Hematol       Date:  2012-03-21       Impact factor: 2.490

2.  Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.

Authors:  Chenan Zhang; Adam J de Smith; Ivan V Smirnov; John K Wiencke; Joseph L Wiemels; John S Witte; Kyle M Walsh
Journal:  J Neurooncol       Date:  2017-07-18       Impact factor: 4.130

3.  HLA polymorphisms and risk of glioblastoma in Koreans.

Authors:  Sang-Soo Choi; Haeyoun Choi; In-Cheol Baek; Soon A Park; Jae-Sung Park; Tai-Gyu Kim; Sin-Soo Jeun; Stephen Ahn
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.